Log in
NYSEARCA:ALIBX

ALPS | Smith Balanced Opportunity Fund - Investor Stock Forecast, Price & News

$10.14
0.00 (0.00 %)
(As of 10/21/2020 12:00 AM ET)
Add
Today's Range
$10.14
Now: $10.14
$10.14
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Basic Details

Issuer
Fund NameALPS | Smith Balanced Opportunity Fund - Investor
Tax Classification
SymbolNYSEARCA:ALIBX
Inception Date1/1/2100
Fund Manager
WebN/A
PhoneN/A

Fund Focus

Asset Class
Benchmark
Category
Focus
Development Level
Region

Fund Statistics

Assets Under Management$499,984.56
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.00%
Other Expenses0.00%
Total Expenses0.00%
Fee Waiver0.00%
Net Expenses0.00%

Administrator, Advisor and Custodian

Administrator
Advisor
Custodian
Distributor
Transfer Agent
Trustee
Lead Market Maker
$10.14
0.00 (0.00 %)
(As of 10/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ALIBX News and Ratings via Email

Sign-up to receive the latest news and ratings for ALIBX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ALPS | Smith Balanced Opportunity Fund - Investor (NYSEARCA:ALIBX) Frequently Asked Questions

What is ALPS | Smith Balanced Opportunity Fund - Investor's stock symbol?

ALPS | Smith Balanced Opportunity Fund - Investor trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "ALIBX."

How do I buy shares of ALPS | Smith Balanced Opportunity Fund - Investor?

Shares of ALIBX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ALPS | Smith Balanced Opportunity Fund - Investor's stock price today?

One share of ALIBX stock can currently be purchased for approximately $10.14.

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.